Cardiovascular risk in severe mental illness: is there a right intervention?

nick-fewings-ka7REB1AJl4-unsplash

A group of Masters Students from the University of Glasgow Global Mental Health MSc write about the Primrose trial, which looked at the clinical and cost-effectiveness of an intervention for reducing cholesterol and cardiovascular risk in severe mental illness.

[read the full story...]

Antipsychotics and metabolic function in people with schizophrenia

Featured

Peter Haddad and Sami Ouanes review a network meta-analysis of the impact of antipsychotic drugs on metabolic function in people with schizophrenia.

[read the full story...]

Statins for dementia prevention: well-tolerated, but Cochrane highlight lack of evidence

14799938159_ad8a4fdd8a_k

Rosalyn Nelson summarises a recently updated Cochrane systematic review of statins for dementia prevention, which finds no evidence to support their use.

[read the full story...]